Professor Cris Print
Cris graduated in Medicine from the University of Auckland in 1989. He worked as a house surgeon and undertook asthma research in Dunedin before completing a Immunology PhD in Auckland under Professor Jim Watson and Dr Geoff Krissansen. He used transgenic technologies to research apoptosis in Melbourne, Australia, before moving to Cambridge University, UK, where he used genomics to research angiogenesis and reproduction, and was a fellow of St Edmund’s College. He co-founded a public genomics and bioinformatics company in Japan before returning to New Zealand in 2005 where he has been using genomics to better understand human pathology, with special focus on cancer. Cris is currently a Professor in the University's Department of Molecular Medicine and Pathology, a Principal Investigator in the Maurice Wilkins Centre, on the Science Leadership Team of the Healthier Lives National Science Challenge, Chair of Scientific Advisory Board of the Auckland Regional Tissue Bank and Vice President of the Auckland Museum Institute. He is immediate past Director of the NZ Bioinformatics Institute and immediate past President of the New Zealand Society for Oncology.
Research | Current
Selected publications and creative works (Research Outputs)
- Muthukaruppan, A., Lasham, A., Blenkiron, C., Woad, K. J., Black, M. A., Knowlton, N., ... Shelling, A. N. (2017). Gene expression profiling of breast tumours from New Zealand patients. The New Zealand medical journal, 130 (1464), 40-56.
Other University of Auckland co-authors: Michael Findlay, Annette Lasham, Cherie Blenkiron, Andrew Shelling, Anita Muthukaruppan
- Muthukaruppan, A., Lasham, A., Woad, K. J., Black, M. A., Blenkiron, C., Miller, L. D., ... Shelling, A. N. (2017). Multimodal assessment of estrogen receptor mRNA profiles to quantify estrogen pathway activity in breast tumors. Clinical Breast Cancer, 17 (2), 139-153. 10.1016/j.clbc.2016.09.001
Other University of Auckland co-authors: Michael Findlay, Andrew Shelling, Annette Lasham, Cherie Blenkiron, Anita Muthukaruppan
- Harris, G., O'Toole S, George, P., Browett, P., & Print, C. (2017). Massive parallel sequencing of solid tumours - challenges and opportunities for pathologists. Histopathology, 70 (1), 123-133. 10.1111/his.13067
Other University of Auckland co-authors: Peter Browett
- Mehta, S., Tsai, P., Lasham, A., Campbell, H., Reddel, R., Braithwaite, A., & Print, C. (2016). A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology. Cancer research, 76 (24), 7151-7159. 10.1158/0008-5472.can-16-1624
Other University of Auckland co-authors: Annette Lasham, Peter Tsai
- Tomek, P., Hallermayr, A., Print, C. G., Sattlegger, E., & Ching, L. (2016). The impact of IMPACT on cancer cell survival during tryptophan deprivation. Paper presented at New Zealand Society for Oncology conference 2016, Palmerston North, New Zealand. 25 October - 26 October 2016.
Other University of Auckland co-authors: Petr Tomek, Lai-Ming Ching
- Lasham, A., Mehta, S. Y., Fitzgerald, S. J., Woolley, A. G., Hearn, J. I., Hurley, D. G., ... Braithwaite, A. W. (2016). A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line. International journal of cancer, 139 (5), 1157-1170. 10.1002/ijc.30137
Other University of Auckland co-authors: Andrew Shelling, Annette Lasham, James Hearn
- Miller, L. D., Chou, J. A., Black, M. A., Print, C., Chifman, J., Alistar, A., ... Hendrickx, W. (2016). Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness. Cancer immunology research, 4 (7), 600-610. 10.1158/2326-6066.cir-15-0149
- Sheppard, H. M., Feisst, V., Chen, J., Print, C., & Dunbar, P. R. (2016). AHNAK is downregulated in melanoma, predicts poor outcome, and may be required for the expression of functional cadherin-1. Melanoma research, 26 (2), 108-116. 10.1097/cmr.0000000000000228
Other University of Auckland co-authors: Hilary Sheppard, Vaughan Feisst, Rod Dunbar